ADRA2B and myalgic encephalomeyelitis/chronic fatigue syndrome: Based on ME/CFS symptoms related to central nervous system function, an early study investigated several AAb against neurotransmitter G protein-coupled receptors (GPCRs) and found a significant increase in AAb targeting M1-muscarinic receptors [17].